Marta Di Martile Selected Research

Marta Di Martile Research Topics

Disease

20	Neoplasms (Cancer) 05/2024 - 11/2013
17	Melanoma (Melanoma, Malignant) 05/2024 - 11/2013
3	Lung Neoplasms (Lung Cancer) 06/2020 - 10/2014
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2022
2	Carcinogenesis 05/2021 - 01/2016
2	Hypoxia (Hypoxemia) 04/2021 - 11/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2016 - 10/2014
1	Leukemia 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023
1	Sarcoma (Soft Tissue Sarcoma) 02/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Adenocarcinoma 10/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2014

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 07/2023 - 11/2013
4	MicroRNAs (MicroRNA)IBA 11/2023 - 12/2016
3	Apoptosis Regulatory ProteinsIBA 07/2023 - 01/2022
3	Transcription Factors (Transcription Factor)IBA 04/2021 - 01/2018
3	Histone Acetyltransferases (Histone Acetyltransferase)IBA 06/2020 - 03/2016
2	Small Interfering RNA (siRNA)IBA 05/2024 - 12/2017
2	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2023 - 04/2022
2	CytokinesIBA 07/2023 - 01/2020
2	venetoclaxIBA 01/2023 - 01/2022
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 05/2021
2	Volatile Oils (Essential Oils)IBA 05/2021 - 09/2020
2	Semaphorins (Semaphorin)IBA 04/2021 - 11/2018
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2020 - 11/2013
2	EnzymesIBA 06/2020 - 01/2016
2	Conditioned Culture MediaIBA 06/2020 - 11/2013
2	Lysine AcetyltransferasesIBA 06/2020 - 01/2016
2	givinostat hydrochlorideIBA 02/2018 - 10/2014
2	Histone Deacetylase InhibitorsIBA 02/2018 - 10/2014
2	Histones (Histone)IBA 01/2018 - 01/2016
1	NestinIBA 11/2023
1	Interleukin-8 (Interleukin 8)IBA 07/2023
1	bcl-X ProteinIBA 07/2023
1	Chemokine CCL5IBA 07/2023
1	ChemokinesIBA 07/2023
1	NF-kappa B (NF-kB)IBA 07/2023
1	Neutralizing AntibodiesIBA 07/2023
1	PhytochemicalsIBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Lipid NanoparticlesIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Tyrosine (L-Tyrosine)FDA Link 01/2023
1	src-Family KinasesIBA 01/2023
1	Caspase 8 (Caspase-8)IBA 01/2023
1	Indicators and Reagents (Reagents)IBA 04/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Tea Tree OilIBA 05/2021
1	terpinenol-4IBA 05/2021
1	trametinibIBA 05/2021
1	dabrafenibIBA 05/2021
1	Oxygen (Dioxygen)IBA 04/2021
1	Glycoproteins (Glycoprotein)IBA 04/2021
1	NeuropilinsIBA 04/2021
1	TubulinIBA 06/2020
1	Angiogenesis InhibitorsIBA 06/2020
1	Chemotactic FactorsIBA 01/2020
1	Culture MediaIBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Messenger RNA (mRNA)IBA 11/2018
1	Proto-Oncogene Proteins c-mybIBA 11/2018
1	ChromatinIBA 11/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	AcetyltransferasesIBA 01/2018
1	Transient Receptor Potential ChannelsIBA 12/2016
1	HydrazonesIBA 03/2016
1	ThiazolesIBA 03/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2014
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2014
1	Pemetrexed (MTA)FDA Link 10/2014
1	Hypoxia-Inducible Factor 1IBA 11/2013

Therapy/Procedure

17	Therapeutics 05/2024 - 01/2016
1	Drug Therapy (Chemotherapy) 01/2023
1	Aftercare (After-Treatment) 01/2022
1	Complementary Therapies (Alternative Medicine) 09/2020